Literature DB >> 28589536

Distinguishing pathogenic mutations from background genetic noise in cardiology: The use of large genome databases for genetic interpretation.

J Ghouse1, M W Skov1, R S Bigseth1, G Ahlberg1, J K Kanters2, M S Olesen1.   

Abstract

Advances in clinical genetic testing have led to increased insight into the human genome, including how challenging it is to interpret rare genetic variation. In some cases, the ability to detect genetic mutations exceeds the ability to understand their clinical impact, limiting the advantage of these technologies. Obstacles in genomic medicine are many and include: understanding the level of certainty/uncertainty behind pathogenicity determination, the numerous different variant interpretation-guidelines used by clinical laboratories, delivering the certain or uncertain result to the patient, helping patients evaluate medical decisions in light of uncertainty regarding the consequence of the findings. Through publication of large publicly available exome/genome databases, researchers and physicians are now able to highlight dubious variants previously associated with different cardiac traits. Also, continuous efforts through data sharing, international collaborative efforts to develop disease-gene-specific guidelines, and computational analyses using large data, will indubitably assist in better variant interpretation and classification. This article discusses the current, and quickly changing, state of variant interpretation resources within cardiovascular genetic research, e.g., publicly available databases and ways of how cardiovascular genetic counselors and geneticists can aid in improving variant interpretation in cardiology.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  ClinGen; false-positive; genetics; inherited cardiac disease; long QT syndrome; online databases

Mesh:

Year:  2017        PMID: 28589536     DOI: 10.1111/cge.13066

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  10 in total

1.  ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation.

Authors:  Edgar A Rivera-Muñoz; Laura V Milko; Steven M Harrison; Danielle R Azzariti; C Lisa Kurtz; Kristy Lee; Jessica L Mester; Meredith A Weaver; Erin Currey; William Craigen; Charis Eng; Birgit Funke; Madhuri Hegde; Ray E Hershberger; Rong Mao; Robert D Steiner; Lisa M Vincent; Christa L Martin; Sharon E Plon; Erin Ramos; Heidi L Rehm; Michael Watson; Jonathan S Berg
Journal:  Hum Mutat       Date:  2018-11       Impact factor: 4.878

2.  Reappraisal of variants previously linked with sudden infant death syndrome: results from three population-based cohorts.

Authors:  Christian Paludan-Müller; Jonas Ghouse; Oliver B Vad; Cecilie B Herfelt; Pia Lundegaard; Gustav Ahlberg; Nicole Schmitt; Jesper H Svendsen; Stig Haunsø; Henning Bundgaard; Torben Hansen; Jørgen K Kanters; Morten S Olesen
Journal:  Eur J Hum Genet       Date:  2019-05-01       Impact factor: 4.246

3.  Mutation saturation for fitness effects at human CpG sites.

Authors:  Ipsita Agarwal; Molly Przeworski
Journal:  Elife       Date:  2021-11-22       Impact factor: 8.140

4.  Can Precision Medicine Actually Help People Like Me? African American and Hispanic Perspectives on the Benefits and Barriers of Precision Medicine.

Authors:  Vivian M Yeh; Erin M Bergner; Marino A Bruce; Sunil Kripalani; Victoria B Mitrani; Titilola A Ogunsola; Consuelo H Wilkins; Derek M Griffith
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

5.  Changes in genetic variant results over time in pediatric cardiomyopathy and electrophysiology.

Authors:  Sara Cherny; Rachael Olson; Kathryn Chiodo; Lauren C Balmert; Gregory Webster
Journal:  J Genet Couns       Date:  2020-07-24       Impact factor: 2.537

6.  Clinotator: analyzing ClinVar variation reports to prioritize reclassification efforts.

Authors:  Robert R Butler Iii; Pablo V Gejman
Journal:  F1000Res       Date:  2018-04-13

7.  Clinical validity assessment of genes for inclusion in multi-gene panel testing: A systematic approach.

Authors:  Tricia N Zion; Bess Wayburn; Sourat Darabi; Devon Lamb Thrush; Erica D Smith; Tami Johnston; Brissa Martin; Kelly D F Hagman; Melissa Parra; Christian Antolik
Journal:  Mol Genet Genomic Med       Date:  2019-03-21       Impact factor: 2.183

8.  Association between Paraoxonase-1 p.Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population.

Authors:  David Corredor-Orlandelli; Santiago Sambracos-Parrado; Santiago Mantilla-García; Josué Tovar-Tirado; Valentina Vega-Ramírez; Santiago David Mendoza-Ayús; Laura Catalina Peña; María Fernanda Leal; Juliana Rodríguez-Carrillo; Juanita León-Torres; Juan Mauricio Pardo-Oviedo; Katherine Parra Abaunza; Nora Contreras Contreras Bravo; Oscar Ortega-Recalde; Dora Janeth Fonseca Mendoza
Journal:  Vasc Health Risk Manag       Date:  2021-11-03

9.  Discerning the Ambiguous Role of Missense TTN Variants in Inherited Arrhythmogenic Syndromes.

Authors:  Estefanía Martínez-Barrios; Georgia Sarquella-Brugada; Alexandra Pérez-Serra; Anna Fernández-Falgueras; Sergi Cesar; Mónica Coll; Marta Puigmulé; Anna Iglesias; Mireia Alcalde; Marta Vallverdú-Prats; Carles Ferrer-Costa; Bernat Del Olmo; Ferran Picó; Laura López; Victoria Fiol; José Cruzalegui; Clara Hernández; Elena Arbelo; Simone Grassi; Antonio Oliva; Rocío Toro; Josep Brugada; Ramon Brugada; Oscar Campuzano
Journal:  J Pers Med       Date:  2022-02-08

10.  Clinical impact of rare variants associated with inherited channelopathies: a 5-year update.

Authors:  Ramon Brugada; Oscar Campuzano; Georgia Sarquella-Brugada; Anna Fernandez-Falgueras; Sergi Cesar; Elena Arbelo; Mónica Coll; Alexandra Perez-Serra; Marta Puigmulé; Anna Iglesias; Mireia Alcalde; Marta Vallverdú-Prats; Victoria Fiol; Carles Ferrer-Costa; Bernat Del Olmo; Ferran Picó; Laura Lopez; Ana García-Alvarez; Paloma Jordà; Coloma Tiron de Llano; Rocío Toro; Simone Grassi; Antonio Oliva; Josep Brugada
Journal:  Hum Genet       Date:  2021-09-21       Impact factor: 5.881

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.